skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,437  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction
Material Type:
Article
Add to My Research

Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction

Cardiovascular diabetology, 2019-08, Vol.18 (1), p.107-107, Article 107 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-019-0914-1 ;PMID: 31429767

Full text available

2
Preclinical development of a miR-132 inhibitor for heart failure treatment
Material Type:
Article
Add to My Research

Preclinical development of a miR-132 inhibitor for heart failure treatment

Nature communications, 2020-01, Vol.11 (1), p.633-10, Article 633 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-14349-2 ;PMID: 32005803

Full text available

3
Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
Material Type:
Article
Add to My Research

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF

Cardiovascular diabetology, 2021-01, Vol.20 (1), p.7-7, Article 7 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-020-01208-z ;PMID: 33413413

Full text available

4
The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
Material Type:
Article
Add to My Research

The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats

Cardiovascular diabetology, 2019-04, Vol.18 (1), p.45-45, Article 45 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-019-0849-6 ;PMID: 30935417

Full text available

5
Association with Controlling Nutritional Status (CONUT) Score and In-hospital Mortality and Infection in Acute Heart Failure
Material Type:
Article
Add to My Research

Association with Controlling Nutritional Status (CONUT) Score and In-hospital Mortality and Infection in Acute Heart Failure

Scientific reports, 2020-02, Vol.10 (1), p.3320-3320, Article 3320 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-60404-9 ;PMID: 32094392

Full text available

6
Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis

BMC cardiovascular disorders, 2020-12, Vol.20 (1), p.512-512, Article 512 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2261 ;EISSN: 1471-2261 ;DOI: 10.1186/s12872-020-01725-5 ;PMID: 33297975

Full text available

7
Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction
Material Type:
Article
Add to My Research

Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction

Nature communications, 2021-03, Vol.12 (1), p.1684-14, Article 1684 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-21931-9 ;PMID: 33727534

Full text available

8
Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis
Material Type:
Article
Add to My Research

Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis

Scientific reports, 2020-05, Vol.10 (1), p.7507-7507, Article 7507 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-64558-4 ;PMID: 32371911

Full text available

9
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
Material Type:
Article
Add to My Research

Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

Nature communications, 2020, Vol.11 (1), p.163-12, Article 163 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-13690-5 ;PMID: 31919418

Full text available

10
Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients
Material Type:
Article
Add to My Research

Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients

Scientific reports, 2019-05, Vol.9 (1), p.6743-6743, Article 6743 [Peer Reviewed Journal]

The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-019-42937-w ;PMID: 31043697

Full text available

11
Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure
Material Type:
Article
Add to My Research

Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure

Scientific reports, 2020-05, Vol.10 (1), p.8158-8158, Article 8158 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-65098-7 ;PMID: 32424129

Full text available

12
Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions
Material Type:
Article
Add to My Research

Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions

BMC Medicine, 2023-02, Vol.21 (1), p.54-54, Article 54 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-023-02764-3 ;PMID: 36782248

Full text available

13
Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction
Material Type:
Article
Add to My Research

Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction

Nature communications, 2019-04, Vol.10 (1), p.1802-1802, Article 1802 [Peer Reviewed Journal]

The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-09530-1 ;PMID: 30996254

Full text available

14
Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure
Material Type:
Article
Add to My Research

Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure

Nature communications, 2019-06, Vol.10 (1), p.2760-14, Article 2760 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-10591-5 ;PMID: 31235787

Full text available

15
The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study
Material Type:
Article
Add to My Research

The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study

Journal of cardiovascular magnetic resonance, 2018-12, Vol.20 (1), p.88-88, Article 88 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1532-429X ;ISSN: 1097-6647 ;EISSN: 1532-429X ;DOI: 10.1186/s12968-018-0511-6 ;PMID: 30580760

Full text available

16
Prognostic value of galectin-3 and right ventricular function for long-term mortality in heart failure patients treated with cardiac resynchronization therapy
Material Type:
Article
Add to My Research

Prognostic value of galectin-3 and right ventricular function for long-term mortality in heart failure patients treated with cardiac resynchronization therapy

Scientific reports, 2021-11, Vol.11 (1), p.21390-21390, Article 21390 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-00984-2 ;PMID: 34725435

Full text available

17
Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)
Material Type:
Article
Add to My Research

Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)

Scientific reports, 2022-02, Vol.12 (1), p.2795-2795, Article 2795 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-022-06698-3 ;PMID: 35181700

Full text available

18
Cardiac remodeling and arrhythmogenesis are ameliorated by administration of Cx43 mimetic peptide Gap27 in heart failure rats
Material Type:
Article
Add to My Research

Cardiac remodeling and arrhythmogenesis are ameliorated by administration of Cx43 mimetic peptide Gap27 in heart failure rats

Scientific reports, 2020-04, Vol.10 (1), p.6878, Article 6878 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-63336-6 ;PMID: 32327677

Full text available

19
Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice
Material Type:
Article
Add to My Research

Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice

Nature communications, 2024-02, Vol.15 (1), p.1352-1352 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-45440-7 ;PMID: 38409164

Full text available

20
Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
Material Type:
Article
Add to My Research

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure

Scientific reports, 2019-06, Vol.9 (1), p.8552-8552, Article 8552 [Peer Reviewed Journal]

The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-019-44912-x ;PMID: 31189919

Full text available

Results 1 - 20 of 6,437  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2002  (8)
  2. 2002 To 2006  (59)
  3. 2007 To 2011  (323)
  4. 2012 To 2017  (1,478)
  5. After 2017  (4,569)
  6. More options open sub menu

Resource Type 

  1. Articles  (6,436)
  2. Reviews  (1)
  3. More options open sub menu

Language 

  1. Japanese  (558)
  2. Norwegian  (10)
  3. Portuguese  (8)
  4. Italian  (2)
  5. French  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait